Header Logo

Connection

ABDUL DIWAN to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications ABDUL DIWAN has written about Dose-Response Relationship, Drug.
ABDUL DIWAN
Connection Strength
0.019
Dose-Response Relationship, Drug
  1. A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res. 2012 Aug; 22(4):294-301.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.